All In Biotech

Drug Trial Radar · NCT05725291

AMT-116 in Patients With Advanced Solid Tumors

First-in-Human, Phase 1 Study of AMT-116 in Patients With Advanced Solid Tumors

Last checked: Nov 19, 2026Latest source record: Aug 17, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

80

Planned (sponsor's estimate)

Start

Jul 25, 2023

Primary completion

Dec 30, 2026

Study completion Dec 30, 2026

Sponsor

Lead sponsor
Multitude Therapeutics Inc.Industry
Sponsor type
Industry
First posted
Feb 13, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This first-in-human study will evaluate the Maximum Tolerated Dose (MTD) / the Recommended Phase 2 Dose (RP2D), safety, tolerability, anti-tumor activity, pharmacokinetics, pharmacodynamics and immunogenicity of AMT-116, in Patients with Advanced Solid Tumors

Conditions

  • Advanced Solid Tumor

Interventions

  • AMT-116Drug

    Administered intravenously

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Recommended Phase 2 Dose (RP2D)Time frame: Up to 24 months
  2. Maximum Tolerated Dose (MTD)Time frame: Up to 24 months
  3. Type, incidence and severity of Adverse EventsTime frame: Up to 24 months

Locations

10 sites in 3 countries. Site status is shown where the registry gives one.

  • Sarah Cannon Research Institute

    Denver, Colorado · Not yet recruiting

  • Mary Crowley Cancer Research Centers

    Dallas, Texas · Recruiting

  • University of California San Francisco Cancer Center

    San Francisco, California, American Samoa · Not yet recruiting

  • Carolina BioOncology Institute, LLC

    Cary, North Carolina, American Samoa · Recruiting

  • Macquarie University Hospital

    Sydney, New South Wales, Australia · Recruiting

  • ICON Cancer Centre

    Brisbane, Queensland, Australia · Recruiting

  • Southern Oncology Clinical Research Unit

    Adelaide, South Australia, Australia · Recruiting

  • Alfred Hospital

    Victoria Park, Victoria, Australia · Recruiting

  • Austin Health

    Victoria Park, Victoria, Australia · Recruiting

  • Cabrini Hospital

    Victoria Park, Victoria, Australia · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.